Yoshiharu Shimomura Selected Research

Yoshiharu Shimomura Research Topics

Disease

7	Body Weight (Weight, Body) 11/2021 - 10/2002
5	Type 2 Diabetes Mellitus (MODY) 01/2020 - 08/2008
4	Insulin Resistance 08/2021 - 03/2006
3	Obesity 11/2021 - 01/2013
3	Atrophy 06/2020 - 08/2006
2	Hyperinsulinism (Hyperinsulinemia) 08/2021 - 03/2010
2	Muscular Atrophy (Muscle Atrophy) 06/2020 - 08/2011
2	Hepatocellular Carcinoma (Hepatoma) 12/2011 - 01/2004
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2006 - 01/2004
2	Liver Failure 03/2004 - 01/2004
1	Overweight 08/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Heart Failure 01/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2020
1	Disease Progression 01/2017
1	Malnutrition (Nutritional Deficiencies) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Hypertrophy 01/2016
1	Ketosis 01/2014
1	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2014
1	Beta-Hydroxyisobutyryl CoA Deacylase Deficiency 01/2014
1	Dyslipidemias (Dyslipidemia) 06/2012
1	Inflammation (Inflammations) 06/2012
1	Fatty Liver 06/2012
1	Hyperlipidemias (Hyperlipidemia) 05/2012
1	Glucose Intolerance 05/2012
1	Liver Neoplasms (Liver Cancer) 12/2011
1	Myalgia 06/2010
1	Liver Diseases (Liver Disease) 01/2006
1	Foodborne Diseases 01/2005
1	Diabetes Mellitus 09/2004
1	End Stage Liver Disease 03/2004

Drug/Important Bio-Agent (IBA)

11	Branched-Chain Amino AcidsIBA 11/2021 - 01/2004
6	Glucose (Dextrose)FDA LinkGeneric 08/2021 - 03/2006
5	Proteins (Proteins, Gene)FDA Link 06/2020 - 08/2006
5	Leucine (L-Leucine)FDA Link 01/2014 - 06/2009
4	Insulin (Novolin)FDA Link 08/2021 - 03/2006
4	Valine (L-Valine)FDA Link 01/2014 - 06/2009
4	Isoleucine (L-Isoleucine)FDA Link 01/2014 - 06/2009
3	1-kestoseIBA 08/2021 - 01/2016
3	EnzymesIBA 01/2014 - 01/2004
3	AcidsIBA 01/2013 - 01/2004
3	Phosphotransferases (Kinase)IBA 05/2012 - 01/2006
2	TOR Serine-Threonine KinasesIBA 06/2020 - 08/2011
2	Butyrates (Butyrate)IBA 01/2020 - 01/2016
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2016 - 01/2014
2	Pharmaceutical PreparationsIBA 01/2014 - 05/2012
2	Oxidoreductases (Dehydrogenase)IBA 01/2013 - 05/2012
2	Triglycerides (Triacylglycerol)IBA 06/2012 - 05/2012
2	Cyclin D1IBA 12/2011 - 08/2011
2	DextrinsIBA 06/2010 - 06/2009
2	3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) (Alpha-Keto Acid Dehydrogenase)IBA 10/2009 - 03/2004
1	PrebioticsIBA 08/2021
1	Valsartan (Vals)FDA Link 01/2021
1	Angiotensin IIIBA 06/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	Choline (Choline Chloride)IBA 01/2017
1	Acetates (Acetic Acid Esters)FDA Link 01/2016
1	Pyruvic Acid (Pyruvate)IBA 01/2014
1	3-hydroxyisobutyryl-CoA hydrolaseIBA 01/2014
1	Amino Acids FDA Link 01/2014
1	CorticosteroneIBA 12/2013
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 06/2012
1	CholesterolIBA 06/2012
1	InterleukinsIBA 06/2012
1	ApolipoproteinsIBA 06/2012
1	Lipoproteins (Lipoprotein)IBA 06/2012
1	VLDL LipoproteinsIBA 06/2012
1	Clofibrate FDA Link 05/2012
1	Messenger RNA (mRNA)IBA 12/2011
1	Peroxisome ProliferatorsIBA 12/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2011
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 12/2011
1	UbiquitinIBA 08/2011
1	RNA (Ribonucleic Acid)IBA 08/2011
1	Ligases (Synthetase)IBA 08/2011
1	Peptide Initiation Factors (Initiation Factor)IBA 08/2011
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 08/2011
1	F-Box ProteinsIBA 08/2011
1	(3-methyl-2-oxobutanoate dehydrogenase (lipoamide)) kinaseIBA 03/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2005
1	EmeticsIBA 01/2005
1	cereulideIBA 01/2005
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 09/2004
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 03/2004
1	methacrylyl-coenzyme AIBA 01/2004
1	Streptozocin (Streptozotocin)FDA Link 10/2002

Therapy/Procedure

1	Hepatectomy 12/2011